rs144176855

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong

The NM_001365999.1(SZT2):ā€‹c.2888A>Gā€‹(p.Lys963Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000267 in 1,614,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K963E) has been classified as Likely benign.

Frequency

Genomes: š‘“ 0.00021 ( 0 hom., cov: 32)
Exomes š‘“: 0.00027 ( 0 hom. )

Consequence

SZT2
NM_001365999.1 missense

Scores

1
6
11

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 4.78
Variant links:
Genes affected
SZT2 (HGNC:29040): (SZT2 subunit of KICSTOR complex) The protein encoded by this gene is expressed in the brain, predominantly in the parietal and frontal cortex as well as in dorsal root ganglia. It is localized to the peroxisome, and is implicated in resistance to oxidative stress. It likely functions by increasing superoxide dismutase (SOD) activity, but itself has no direct SOD activity. Studies in mice show that this gene confers low seizure threshold, and may also enhance epileptogenesis. [provided by RefSeq, Jun 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SZT2. . Gene score misZ 2.5968 (greater than the threshold 3.09). Trascript score misZ 4.0086 (greater than threshold 3.09). GenCC has associacion of gene with undetermined early-onset epileptic encephalopathy, developmental and epileptic encephalopathy, 18, developmental and epileptic encephalopathy.
BP4
Computational evidence support a benign effect (MetaRNN=0.01940599).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SZT2NM_001365999.1 linkuse as main transcriptc.2888A>G p.Lys963Arg missense_variant 20/72 ENST00000634258.3
SZT2NM_015284.4 linkuse as main transcriptc.2888A>G p.Lys963Arg missense_variant 20/71

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SZT2ENST00000634258.3 linkuse as main transcriptc.2888A>G p.Lys963Arg missense_variant 20/725 NM_001365999.1 P1Q5T011-1
SZT2ENST00000562955.2 linkuse as main transcriptc.2888A>G p.Lys963Arg missense_variant 20/715 Q5T011-5
SZT2ENST00000470139.1 linkuse as main transcriptc.1619A>G p.Lys540Arg missense_variant, NMD_transcript_variant 11/182

Frequencies

GnomAD3 genomes
AF:
0.000210
AC:
32
AN:
152170
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000362
AC:
91
AN:
251482
Hom.:
0
AF XY:
0.000316
AC XY:
43
AN XY:
135918
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000198
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000508
Gnomad NFE exome
AF:
0.000659
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000273
AC:
399
AN:
1461878
Hom.:
0
Cov.:
33
AF XY:
0.000248
AC XY:
180
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.000459
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000618
Gnomad4 NFE exome
AF:
0.000308
Gnomad4 OTH exome
AF:
0.000199
GnomAD4 genome
AF:
0.000210
AC:
32
AN:
152170
Hom.:
0
Cov.:
32
AF XY:
0.000175
AC XY:
13
AN XY:
74344
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.000309
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000345
Hom.:
0
Bravo
AF:
0.000332
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000601
AC:
73
EpiCase
AF:
0.000273
EpiControl
AF:
0.000474

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 04, 2022This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 963 of the SZT2 protein (p.Lys963Arg). This variant is present in population databases (rs144176855, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with SZT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 411928). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SZT2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsSep 26, 2017- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 21, 2023Variant summary: C1orf84 c.2888A>G (p.Lys963Arg) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00034 in 282858 control chromosomes (gnomAD). To our knowledge, no occurrence of c.2888A>G in individuals affected with Early Infantile Epileptic Encephalopathy 18 and no experimental evidence demonstrating its impact on protein function have been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Developmental and epileptic encephalopathy, 18 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 18, 2021The c.2888A>G (p.K963R) alteration is located in exon 20 (coding exon 20) of the SZT2 gene. This alteration results from a A to G substitution at nucleotide position 2888, causing the lysine (K) at amino acid position 963 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.24
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.098
T;.
Eigen
Uncertain
0.26
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.84
T;T
M_CAP
Benign
0.0031
T
MetaRNN
Benign
0.019
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Uncertain
2.0
M;M
MutationTaster
Benign
0.98
N;N
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.4
.;N
Sift
Benign
0.097
.;T
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.86
.;P
Vest4
0.34
MVP
0.35
MPC
0.78
ClinPred
0.062
T
GERP RS
6.1
Varity_R
0.38
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144176855; hg19: chr1-43891579; API